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Background: Altered fetal growth is known to be associated with allergic disease. Specif-
ically, increased head circumference at birth has been linked to asthma and elevated IgE.
However, few studies have examined a link between early fetal anthropometry and allergic
disease. The aim of this study was to examine head circumference at mid-gestation in
children diagnosed with allergy.
Methods: This was a retrospective cohort study, comprising pregnancies delivered
between 10/2006 and 9/2010 at Nepean Hospital, Australia. Exclusion criteria were illegal
drug use, alcohol consumption, gestation <35weeks, and gestational hypertension.
Pregnancy data were sourced from the Nepean Obstetric Database. Atopic diseases
(asthma, atopic dermatitis, and IgE-mediated food allergy) were assessed by question-
naire at age 1–5 years. Infants from pregnancies with completed questionnaires, who also
had a mid-gestation ultrasound scan, were included (N=121). Multiple logistic regression
techniques were used to model head circumference against the development of allergies.
Results: Smaller head circumference at mid-gestation was associated with increased
odds of allergic disease in children aged 1–5 years. A 1mm smaller head circumference
was associated with a 7% increased chance of allergies being later diagnosed, adjusted
for gestation (95% CI: 1–14%, p=0.036). Head circumference at mid-gestation was also
inversely correlated with the presence of multiple atopic disease.
Conclusion: Smaller mid-gestational head circumference is associated with early child-
hood allergic disease, which suggests that fetal programing of allergic disease occurs
before mid-gestation. This suggests that mediators such as brain-derived neurotrophic
factor may be dysregulated early in utero in a milieu, which also predisposes to atopic
disease.
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Introduction
Allergic disease is likely programed in utero, as a product of altered
fetal growth and development (1). In support of this theory,
changes in fetal anthropometry, including decreased birth weight
(2) and increased head circumference at birth (3), have been
previously reported to be associatedwith asthma. Furthermore, an
increased head circumference at birth has been linked to elevated
IgE levels in later life (1, 4). Associations between fetal growth
disturbance and allergy have previously been attributed to “brain
sparing,” whereby head growth is maintained in the nutrient-
starved fetus at the expense of less critical organs, including
the thymus (5). Accordingly, impaired thymus development may
have long-term immune consequences, including an increased
risk of allergy. However, in asthma, head and thymus size are
positively correlated and thymus size appears unrelated to asthma
(6), suggesting an alternative mechanism.
More than adequate nutrient supply, brain growth depends
on neurotrophins, including brain-derived neurotrophic factor
(BDNF) (7). In addition to their functions in neurodevelopment,
neurotrophins are present in immune cells and are highly active
in allergic disease (8, 9). Furthermore, BDNF levels correlate
with disease severity in asthma (10), atopic dermatitis (11, 12),
and allergic rhinitis (13). Differential exposure to neurotrophins
in utero may therefore explain altered fetal growth in allergic
disease.
Fetal anthropometry atmid-gestation has not been well studied
in allergy. Hence, the aim of this study was to investigate fetal head
circumference at mid-gestation in allergic disease. It was hypoth-
esized that fetal head size would be altered in fetuses who were
subsequently diagnosed with allergic disease in early childhood.
Materials and Methods
This was a retrospective cohort study, which included subjects
from a larger pre-eclampsia cohort study (Eviston et al; unpub-
lished). Singleton pregnancies delivered between 1/10/2006 and
30/9/2010 at Nepean Hospital, Australia were considered for
inclusion. Exclusion criteria included gestational hypertension,
illegal drug use, alcohol consumption greater than one standard
drink per day, gestation at delivery <35weeks, and birth weight
<2000 g. Eligible pre-eclamptic pregnancies were matched with
non-pre-eclamptic pregnancies (1:2), according to maternal age,
gestation, smoking status, and child’s date of birth.
All procedures contributing to this work comply with the ethi-
cal standards of the relevant national guidelines on human exper-
imentation [National Statement on Ethical Conduct in Human
Research (2007)] and with the Helsinki Declaration of 1975, as
revised in 2008, and approval was granted by The Ethics Commit-
tee of the Sydney West Area Health Service.
Current and past allergic disease was assessed via Comprehen-
sive Early Childhood Allergy Questionnaire (CECAQ), as below
(Appendix A), or a structured phone interview in the event of
no reply. CECAQ is a combined questionnaire designed to detect
three common atopic conditions in the age group of 1–5 years
(asthma, atopic dermatitis, and IgE-mediated food allergies) and is
based on other validated questionnaires, namely the Food Allergy
Questionnaire (14), the ISAAC questionnaire plus its validated
modification (15, 16), and the UK Working Party criteria for
diagnosing atopic eczema (17).
During the data collection period, 15,273 singleton pregnan-
cies were delivered at Nepean Hospital, which included 436 pre-
eclamptic pregnancies. Based on the exclusion criteria, 184 of
these pregnancies were ineligible (Figure 1). The remaining 252
pre-eclamptic pregnancies were matched (1:2) with healthy con-
trol pregnancies (504). Eighteen pregnancies were excluded on
suspicion of child death, and a total of 738 allergy questionnaires
were mailed. Following an attempt at telephone correspondence
for non-responders, 227 completed questionnaires were collected.
Utilizing Viewpoint software, 121 of these pregnant mothers were
found to have a mid-gestation ultrasound scan and were included
in the final cohort.
Head circumference measurements were obtained by clinical
sonographers, as part of a standard mid-gestation ultrasound
protocol. Gestational age was based on an earlier dating scan, or
the first day of the last menstrual period, if a dating scan was not
available.
Pre-eclampsia was defined according to recommendations pro-
posed by the International Society for the Study of Hypertension
in Pregnancy (18).
Case matching pre-eclamptic pregnancies was performed to
identify a possible link between pre-eclampsia and childhood
allergy. Control pregnancies, for each pre-eclamptic case, were the
first two pregnancies encountered from a random list of eligible
pregnancies.
Continuous maternal and fetal characteristics were compared
between atopic and non-atopic groups using two-tailed t-tests
(or Mann–Whitney U-tests where the normality assumption was
violated). Categorical characteristics were compared using either
Fisher’s exact or Chi-square tests, as appropriate to group size.
Similar techniques were used to compare infant variables between
pre-eclamptic and non-pre-eclamptic pregnancies.
Logistic regression techniques were used to model the devel-
opment of allergies (Y/N). Univariate models were initially
performed, with variables significant at p< 0.20 considered for
multivariate modeling (Table 2). A multivariate model was per-
formed which included mid-gestational variables (head circum-
ference at mid-gestation, gestation at ultrasound). The effect of
allergy was also investigated with ordinal logistic regression tech-
niques to model the development of no allergy vs. one allergy vs.
two or more allergic diagnoses (asthma, atopic dermatitis, and
IgE-mediated food allergy) at mid-gestation. The assumption of
proportional odds was met. No adjustments have been made for
multiple comparisons. A two-sided p value< 0.05 was considered
statistically significant. All modeling was performed in SAS v9.3
(SAS Institute Inc., Cary, NC, USA).
Results
Allergic disease and non-allergic disease groups contained a rela-
tively large, but comparable, number of pre-eclamptic pregnan-
cies (34.1 vs. 36.3%, p= 0.81; Table 1). Similar demographic
variables were noted between infants born to pre-eclamptic (43)
and non-pre-eclamptic pregnancies (78), including male baby
(53.5 vs. 51.3%, p= 0.85), any allergic disease (32.6 vs. 34.6%,
p= 0.84), asthma (16.3 vs. 21.8%, p= 0.63), atopic dermatitis
Frontiers in Pediatrics | www.frontiersin.org September 2015 | Volume 3 | Article 732
Eviston et al. Fetal head circumference and allergy
FIGURE 1 | Flow of pregnancies for inclusion.
(18.6 vs. 12.8%, p= 0.43), food allergy (9.3 vs. 9.0%, p= 1.0),
and median child age (2.3 vs. 2.6 years, p= 0.42), respectively.
Head circumference at mid-gestation was also comparable (pre-
eclamptic= 163.5mm, non-pre-eclamptic= 163.2mm, p= 0.86).
Atopic disease was unrelated to pre-eclampsia in univariate anal-
ysis (Table 2).
Maternal and fetal characteristics were comparable in the mid-
gestation analysis, excepting head circumference, which was sig-
nificantly smaller in fetuses later affected by allergy [160.6mm
(SD= 8.9) vs. 164.6mm (SD= 10.4), p= 0.038]. At birth, how-
ever, there was no difference in head circumference mea-
sures (allergy, median= 345mm; no allergy, median= 345mm,
p= 0.73).
Univariate modeling revealed no significant association
between pre-eclampsia and child allergy status (Table 2).
Similarly, nulliparity, gender, cesarian delivery, smoking,
maternal age, and BMI were not statistically associated with
allergy status. Reported family history of allergy was comparable
between families with allergic children, vs. non-allergic children
(82.9 vs. 67.5%, p= 0.09). At mid-gestation, head circumference
was the only anthropometric measure linked to allergy status in
univariate modeling [OR= 0.96 (95% CI: 0.92–0.997), p= 0.037],
which included biparietal diameter, femur length, and abdominal
circumference measures.
Multiple logistic regression revealed small fetal head circum-
ference at mid-gestation to be significantly linked to childhood
allergy, adjusted for gestation at ultrasound, with each decrease
of 1mm associated with an increased risk of 7% increase in
risk of allergy (95% CI: 1–14%, p= 0.036). Furthermore, ordinal
logistic regression analysis found fetal head circumference at mid-
gestation to be related to the number of childhood allergies. For
a patient with no allergies, each 1-mm increase in head circum-
ference corresponds to a 7% increased risk of having an allergy.
Similarly, for a patient with one allergy, each 1-mm increase in
head circumference corresponds to a 7% increased risk of having
two or more allergies. [Figure 2; OR= 0.93 (95% CI: 0.80–0.99),
p= 0.033].
Head circumference at birth was not associated with allergic
disease in univariate modeling [OR= 0.87 (95% CI: 0.73–1.04),
p= 0.13]. Furthermore, head circumference at birth was not
linked to allergy status in multivariate modeling, adjusted for
gestation at delivery and birth weight [OR= 0.91 (95% CI:
0.72–1.15), p= 0.42]. In this multivariate model, childhood
allergy status was also independent of gestation at delivery
[OR= 0.87 (95% CI: 0.72–1.06), p= 0.16] and birth weight
[OR= 1.00 (95% CI: 0.99–1.00), p= 0.97].
Discussion
This is the first study to associate childhood allergywith decreased
head circumference in fetal life. At mid-gestation, fetal head
circumference was inversely related to the number of allergies
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TABLE 1 | Participant characteristics.
Characteristic Allergy
(n= 41)
No Allergy
(n= 80)
P value
Mother
Age (yr) 28.9 (5.4) 30.3 (5.8) 0:18
Body Mass Index (kg.m 2) 27.3 (22.0–31.5) 25.5 (21.0–30.1) 0:38*
Pre-eclampsia 14 (34.1%) 29 (36.3%) 0:84
Cesarian delivery 13 (31.7%) 28 (35.0%) 0:84
Smoking 4 (9.8%) 6 (7.5%) 0:73
Nulliparous 20 (48.8%) 40 (50.0%) 0:99
Family history of allergy 34 (82.9%) 54 (67.5%) 0:09
Child
Age (yr) 2.6 (1.7–3.8) 2.4 (1.5–3.8) 0:67*
Male baby 21 (51.2%) 42 (52.5%) 0:99
Gestation at delivery (wk) 38.8 (1.8) 38.9 (1.3) 0:95*
Birth weight (g) 3298 (491) 3365 (577) 0:86*
Length at birth (cm) 49.8 (4.1) 50.7 (2.9) 0:32*
Head circumference at birth (cm) 34.7 (3.8) 34.6 (1.9) 0:49*
1 allergic disease 30 (73.2%)
2 allergic diseases 11 (26.8%)
Asthma 24 (58.5%)
Atopic dermatitis 18 (43.9%)
Food allergy 11 (26.8%)
Fetal size at mid-gestation
Gestation at ultrasound (wk) 19.2 (0.7) 19.3 (0.8) 0:28
Head circumference (mm) 160.6 (8.9) 164.6 (10.4) 0.038
Biparietal diameter (mm) 43.3 (2.9) 44.1 (3.1) 0:16
Abdominal circumference (mm) 141.7 (9.0) 143.7 (12.1) 0:35
Femur length (mm) 29.8 (2.3) 30.0 (2.8) 0:69
Data expressed as N (%), mean (SD), or median (Q1–Q3).
*Indicates that a Mann–Whitney U-test was performed.
TABLE 2 |Univariate logistic regressionmodels for an outcome of an allergy
vs. no allergy.
Variable Odds ratio (95% CI) P value
Head circumference at
mid-gestation per 1-mm increase
0.96 (0.92, 0.997) 0.037
Pre-eclampsia (N vs. Y) 0.85 (0.50, 1.47) 0.56
Nulliparity (N vs. Y) 1.14 (0.67, 1.95) 0.64
Gender (F vs. M) 0.99 (0.58, 1.69) 0.96
Cesarian delivery (N vs. Y) 1.28 (0.74, 2.21) 0.38
Smoking (N vs. Y) 1.16 (0.45, 2.99) 0.76
Maternal age per year increase 0.98 (0.93, 1.02) 0.34
Maternal BMI per unit increase 0.99 (0.95, 1.03) 0.58
in a given child, suggesting a dose–response in terms of degree
of atopic predisposition and head growth in utero. In multiple
logistic regression analyses, differences in head circumference
remained significant after adjusting for gestational age.
Children in the allergy and no allergy groups were comparable
for all maternal variables, including pre-eclamptic cases. Child
variables were also comparable between groups, excepting head
circumference at mid-gestation. Importantly, the median age of
allergic children was relatively young in this study (2.6 years).
Included children thus represent early onset allergy, and compar-
ison with other studies should bear this consideration.
Changes in anthropometry at birth have been associated with
several adult-onset disease states including hypertension (19) and
coronary artery disease (20). Similarly, a growing body of evi-
dence supports fetal programing in allergic disease. However,
FIGURE 2 | Head circumference at mid-gestation vs. number of
childhood allergies. Tukey boxplot, whereby “” represents a data point
greater than the 75th percentile plus 1.5 times the interquartile range. 0
allergies (N= 80), 1 allergy (N= 30), 2 allergies (N= 11). An inverse
relationship was observed between mid-gestation head circumference and
the number of childhood allergies (p=0.033).
differences in methodology and contradictory findings, com-
bined with restricted access to the fetus, have hindered efforts
to delineate a clear mechanism. For instance, Fergusson et al.,
1997 found increased head circumference at birth to be associ-
ated with asthma, but the same association was not observed for
eczema or allergic rhinitis (3). On the other hand, Carrington
et al., 2006 associated a small head circumference 10–15 days after
birth with childhood wheeze (21). Such inconsistencies highlight
a need for further research in this area. Nevertheless, fetal pro-
graming in atopic disease remains well supported, with increased
head circumference at birth consistently linked to elevated IgE in
childhood and adult life (1, 4, 22).
Decreased fetal head growth early in utero has been linked
to asthma previously (23). However, that particular study uti-
lized biparietal diameter measurements, which were not signifi-
cantly different in our study. A separate cohort study found no
association between fetal head circumference and atopic wheeze;
however, early decreased head growth was linked to non-atopic
wheeze at 3 years, perhaps the result of smaller airways (24).
To our knowledge, no other studies have looked at early fetal
growth and atopic disease, and further research is needed to clarify
inconsistent findings. In view of the relatively young age of our
cohort, a follow-up study is also warranted.
Previous contributors have proposed the “brain sparing”mech-
anism to link changes in fetal anthropometry with atopic disease.
In line with this theory, the fetus may preferentially sustain brain
growth at the expense of “less important” organs, including the
thymus. Accordingly, increased head circumference has been con-
sidered an indirect marker of thymus undernutrition. However, in
this study, childhood allergy was not associated with a statistical
difference in neonatal head circumference. Combined with earlier
and conflicting reports, a link between “brain sparing” and allergic
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disease is not well supported, and alternative mechanisms should
be explored.
Aside from “brain sparing,” changes in neurotrophin exposure
may link altered fetal growth to atopic disease. BDNF and other
neurotrophins are importantmediators of neuronal growth,main-
tenance, and differentiation (25). Alterations in neurotrophins,
as seen in various neuropsychiatric disorders, are also linked to
changes in brain growth and volume (26, 27). Beyond their pri-
mary functions in neurodevelopment, neurotrophins are upregu-
lated in allergic inflammation (8). As well as promoting survival
of eosinophils (28) and plasma cells (9), neurotrophins mediate
chronic airway remodeling in asthma (29).
With a link between neurotrophins and atopic disease estab-
lished, could altered fetal exposure to neurotrophins explain our
findings? In humans, cord blood BDNF normally increases from
mid-gestation onward (30). Accordingly, fetal neurodevelopment
may greatly depend on neurotrophin levels in late gestation. Our
finding of a small fetal head atmid-gestation, and a “normal”-sized
head at birth,might thus reflect a compensatory increased effect of
neurotrophins during this period. However, little is known about
the biology of neurotrophins in utero, and studies are needed to
further explore this hypothesis.
There were four reasons why pre-eclamptic pregnancies were
initially selected and matched in this study. First, pre-eclampsia
is associated with fetal growth restriction (31). Second, we
have earlier shown fetal thymus size to be smaller in pre-
eclampsia (32), with possible implications for child immune
function. Third, limited evidence has linked pre-eclampsia with
atopic sensitization (33). Finally, we have recently found an
altered pattern of fetal head growth in pre-eclampsia, indepen-
dent of growth restriction (Eviston et al., unpublished). How-
ever, despite these known associations, this study found no
significant association between pre-eclampsia and childhood
allergy.
This study is limited by its questionnaire-based design and the
IgE-mediated food allergy component of the CECAQ is yet to
be validated. A completed questionnaire response rate of 30.8%
also raises the possibility of selection bias; however, only 11
persons actively declined participation following an attempt at
telephone correspondence. Hence, the vastmajority of incomplete
questionnaires were due to an inability to contact mothers; an
anticipated problem, since contact details were several years old
in most instances. Mechanistically, our findings are plausible,
but have not been confirmed by fetal biologic data. It is difficult
to envisage a study design which would allow fetal blood sam-
pling, given ethical and logistical concerns. Lastly, since the study
design involved matching pre-eclamptic pregnancies, a potential
for confounding bias was introduced; however, both the allergy
and no allergy groups of children contained a comparable number
of pre-eclamptic pregnancies and variables were similar between
pre-eclamptic and non-pre-eclamptic pregnancies.Moreover, pre-
eclampsia was unrelated to atopy in univariate analysis.
In conclusion, although these findings warrant replication, a
small fetal head circumference atmid-gestation suggests that early
fetal programing and exposures are important in the subsequent
development of allergic disease.
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